Abeille Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$24M Sell
150,226
-596
-0.4% -$211K 0.85% 50
2022
Q3
$48.8M Buy
150,822
+35,383
+31% +$11.2M 1.89% 14
2022
Q2
$37.4M Buy
+115,439
New +$34.7M 1.32% 31

Other funds holding LLY

Abeille Asset Management's LLY Position: Q4 2022 in Review

Abeille Asset Management reduced its Eli Lilly (LLY) stake by 0.4% in Q4 2022, selling an estimated $211K and leaving 150,226 shares worth $24M. The position accounts for 0.85% of the portfolio, ranked #50.

Abeille Asset Management first reported a position in LLY in Q2 2022 and has held it in 3 quarters since. The position peaked at $48.8M in Q3 2022. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Abeille Asset Management held 150,226 shares of Eli Lilly worth $24M as of Q4 2022.
  • Abeille Asset Management sold 596 Eli Lilly shares in Q4 2022, an estimated $211K.
  • Eli Lilly made up 0.85% of Abeille Asset Management's portfolio in Q4 2022, its #50 holding.
  • Abeille Asset Management first reported a position in Eli Lilly in Q2 2022 and has held it in 3 quarters since.
  • Abeille Asset Management's Eli Lilly position peaked at $48.8M in Q3 2022.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Abeille Asset Management's 13F filing for Q4 2022, filed 20 Jan 2023.